By Stephen Beech

Prostate cancer treatment could be "supercharged" by a new way of weakening malignant cells, say scientists.

A new "vulnerability" in prostate cancer cells that could help improve treatment has been discovered by an international team of researchers.

Prostate cancer is the second most common cancer in men worldwide. There are around 56,000 diagnoses and 12,000 deaths each year just in the UK.

But now scientists have found that two enzymes - PDIA1 and PDIA5 - play a "crucial" role in helping prostate cancer cells grow, survive, and resist treatment.

They explained that the enzymes act as "molecular bodyguards" for the androgen receptor (AR), a protein that fuels prostate cancer.

When PDIA1 and PDIA5 are blocked, the AR becomes unstable and breaks down, leading to th

See Full Page